Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report)’s stock price fell 7.4% during mid-day trading on Wednesday . The company traded as low as $1.00 and last traded at $1.00. 155 shares were traded during mid-day trading, a decline of 94% from the average session volume of 2,738 shares. The stock had previously closed at $1.08.
Idorsia Price Performance
The business’s 50 day moving average price is $2.09 and its 200-day moving average price is $2.29.
About Idorsia
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Further Reading
- Five stocks we like better than Idorsia
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Top-Performing Non-Leveraged ETFs This Year
- Golden Cross Stocks: Pattern, Examples and Charts
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
